Changes in the concentrations of creatinine, cystatin C and NGAL in patients with acute paraquat self-poisoning

Toxicology Letters

Volumn 202, Issue 1, 2011, Pages 69-74

  Roberts, Darren M ^a,b   Wilks, Martin F ^c   Roberts, Michael S ^d,e   Swaminathan, Ramasamyiyer ^f   Mohamed, Fahim ^a   Dawson, Andrew H ^a,g,h   Buckley, Nick A ^a,g  

^a UNIVERSITY OF PERADENIYA   (Sri Lanka)

^b ST VINCENT S HOSPITAL   (Australia)

^c UNIVERSITY OF BASEL   (Switzerland)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^f ST THOMAS HOSPITAL   (United Kingdom)

^g UNIVERSITY OF NEW SOUTH WALES   (Australia)

^h CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

Biomarker; Creatinine; Cystatin C; Human; Kidney injury; NGAL; Paraquat; Prognosis

Indexed keywords

CREATININE; CYSTATIN C; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; HUMAN; MORTALITY; PARAQUAT POISONING; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SELF POISONING; SENSITIVITY AND SPECIFICITY; SURVIVOR; TREATMENT OUTCOME;

ACUTE KIDNEY INJURY; ACUTE-PHASE PROTEINS; BIOLOGICAL MARKERS; CREATININE; CYSTATIN C; HERBICIDES; HUMANS; LIPOCALINS; PARAQUAT; POISONING; PROTO-ONCOGENE PROTEINS; SUICIDE, ATTEMPTED;

EID: 79952041388     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2011.01.024     Document Type: Article

References (28)

1. Aitken R.G., Northall H., York G.A. High serum concentrations of paraquat increase apparent creatinine concentrations. Ann. Clin. Biochem. 1994, 31:198-199.
2. Bagshaw S.M., Bellomo R. Cystatin C in acute kidney injury. Curr. Opin. Crit. Care 2010.
3. Bandaranayake N., Ankrah-Tetteh T., Wijeratne S., Swaminathan R. Intra-individual variation in creatinine and cystatin C. Clin. Chem. Lab. Med. 2007, 45:1237-1239.
4. Blake D.K., Gallagher R.T., Woollen B.H. Improved methods for the analysis of paraquat in biological fluids. Chromatographia 2002, 55:S183-S185.
5. Chan B.S., Lazzaro V.A., Seale J.P., Duggin G.G. The renal excretory mechanisms and the role of organic cations in modulating the renal handling of paraquat. Pharmacol. Ther. 1998, 79:193-203.
6. Dawson A.H., Eddleston M., Senarathna L., Mohamed F., Gawarammana I., Bowe S.J., Manuweera G., Buckley N.A. Acute human lethal toxicity of agricultural pesticides: a prospective cohort study. PLoS Med. 2010, 7:e1000357.
7. Eddleston M., Wilks M.F., Buckley N.A. Prospects for treatment of paraquat-induced lung fibrosis with immunosuppressive drugs and the need for better prediction of outcome: a systematic review. Q. J. Med. 2003, 96:809-824.
8. Fairshter R.D., Miyada D.S., Ulich T.R., Tipper P. The effects of paraquat dichloride on clinical chemistry measurements. J. Anal. Toxicol. 1986, 10:162-164.
9. Gil H.W., Kang M.S., Yang J.O., Lee E.Y., Hong S.Y. Association between plasma paraquat level and outcome of paraquat poisoning in 375 paraquat poisoning patients. Clin. Toxicol. 2008, 46:515-518.
10. Gil H.W., Yang J.O., Lee E.Y., Hong S.Y. Clinical implication of urinary neutrophil gelatinase-associated lipocalin and kidney injury molecule-1 in patients with acute paraquat intoxication. Clin. Toxicol. 2009, 47:870-875.
11. Gunnell D., Eddleston M., Phillips M.R., Konradsen F. The global distribution of fatal pesticide self-poisoning: systematic review. BMC Public Health 2007, 7:357.
12. Haase M., Bellomo R., Devarajan P., Schlattmann P., Haase-Fielitz A. Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am. J. Kidney Dis. 2009, 54:1012-1024.
13. Hantson P., Bernard A., Hermans C. Kinetics and determinants of the changes of CC16, a lung secretory protein in a rat model of toxic lung injury. Clin. Toxicol. (Phila.) 2008, 46:230-238.
14. Hantson P., Weynand B., Doyle I., Bernand A., Hermans C. Pneumoproteins as markers of paraquat lung injury: a clinical case. J. Forensic Leg. Med. 2008, 15:48-52.
15. Kim S.J., Gil H.W., Yang J.O., Lee E.Y., Hong S.Y. The clinical features of acute kidney injury in patients with acute paraquat intoxication. Nephrol. Dial. Transplant. 2008.
16. Mayeur N., Rostaing L., Nogier M.B., Jaafar A., Cointault O., Kamar N., Conil J.M., Fourcade O., Lavayssiere L. Kinetics of plasmatic cytokines and cystatin C during and after hemodialysis in septic shock-related acute renal failure. Crit. Care 2010, 14:R115.
17. Pedersen K.R., Ravn H.B., Hjortdal V.E., Norregaard R., Povlsen J.V. Neutrophil gelatinase-associated lipocalin (NGAL): validation of commercially available ELISA. Scand. J. Clin. Lab. Invest. 2010, 70:374-382.
18. Pond S.M., Rivory L.P., Hampson E.C., Roberts M.S. Kinetics of toxic doses of paraquat and the effects of hemoperfusion in the dog. J. Toxicol. Clin. Toxicol. 1993, 31:229-246.
19. Price L.A., Newman K.J., Clague A.E., Wilson P.R., Wenck D.J. Paraquat and diquat interference in the analysis of creatinine by the Jaffe reaction. Pathology 1995, 27:154-156.
20. Ragoucy-Sengler C., Pileire B. A biological index to predict patient outcome in paraquat poisoning. Hum. Exp. Toxicol. 1996, 15:265-268.
21. Sawada Y., Nagai Y., Ueyama M., Yamamoto I. Probable toxicity of surface-active agent in commercial herbicide containing glyphosate. Lancet 1988, 1:299.
22. Senarathna L., Eddleston M., Wilks M.F., Woollen B.H., Tomenson J.A., Roberts D.M., Buckley N.A. Prediction of outcome after paraquat poisoning by measurement of the plasma paraquat concentration. Q. J. Med. 2009, 102:251-259.
23. Vaidya V.S., Ferguson M.A., Bonventre J.V. Biomarkers of acute kidney injury. Annu. Rev. Pharmacol. Toxicol. 2008, 48:463-493.
24. Waikar S.S., Bonventre J.V. Creatinine kinetics and the definition of acute kidney injury. J. Am. Soc. Nephrol. 2009, 20:672-679.
25. Webb D.B., Davies C.G. Paraquat poisoning and kidney function tests. Lancet 1981, 1:1424.
26. Wilks M.F., Fernando R., Ariyananda P.L., Eddleston M., Berry D.J., Tomenson J.A., Buckley N.A., Jayamanne S., Gunnell D., Dawson A. Improvement in survival after paraquat ingestion following introduction of a new formulation in Sri Lanka. PLoS Med. 2008, 5:250-259.
27. Wilks M.F., Tomenson J.A., Fernando R., Ariyananda P.L., Berry D.J., Buckley N.A., Gawarammana I., Jayamanne S., Gunnell D., Dawson A. Formulation changes and time trends in outcome following paraquat ingestion in Sri Lanka. Clinical Toxicology 2011, 49:21-28.
28. Youden W.J. Index for rating diagnostic tests. Cancer 1950, 3:32-35.